GURU.Markets stock price, segment price, and overall market index valuation
The company's share price Johnson Johnson
Johnson & Johnson's share price reflects the stability and diversification of the healthcare sector. The holding company operates in three segments: pharmaceuticals, medical devices, and consumer products. This structure ensures resilience to market fluctuations and stable cash flow.
Share prices of companies in the market segment - Holding
After spinning off its consumer business, Johnson & Johnson focused on two segments: pharmaceuticals and medical devices (MedTech). We classify it as part of the Holding sector, and the chart below reflects the performance of diversified healthcare companies.
Broad Market Index - GURU.Markets
Johnson & Johnson is a diversified healthcare giant, producing everything from consumer goods to pharmaceuticals and medical equipment. Its scale makes it a pillar of the GURU.Markets index. The chart below represents the entire market. Find out how it compares to this giant.
Change in the price of a company, segment, and market as a whole per day
JNJ - Daily change in the company's share price Johnson Johnson
For Johnson & Johnson, a diversified healthcare giant, daily price changes are an indicator of its stability and response to news in the pharmaceutical sector. The chart of these fluctuations is unspectacular, but it is an important component of the formulas on System.GURU.Markets.
Daily change in the price of a set of shares in a market segment - Holding
Johnson & Johnson is a diversified healthcare giant. This chart reflects the average daily volatility of the entire sector, from pharmaceuticals to medical devices. It serves as a benchmark to assess whether JNJ's diversification makes its stock more stable than the industry as a whole.
Daily change in the price of a broad market stock, index - GURU.Markets
Johnson & Johnson is a diversified healthcare giant, producing everything from consumer goods to pharmaceuticals and medical equipment. The company is considered a blue chip, often more stable than the broader market. The chart below shows the overall fluctuations against which J&J's protective nature can be compared.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization Johnson Johnson
Johnson & Johnson completed its transformation last year by spinning off its consumer business into a separate company, Kenvue. J&J is now a giant focused on pharmaceuticals and medical devices. The chart below shows how investors viewed this new, more focused strategy and the potential of its key products.
Annual dynamics of market capitalization of the market segment - Holding
Johnson & Johnson is a diversified healthcare giant whose stability rests on three pillars: pharmaceuticals, medical devices, and consumer goods. This approach mitigates the risks inherent in individual segments, making its shares less volatile than many of its competitors. The chart below shows its performance as a safe haven in the sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Johnson & Johnson is a diversified healthcare giant, combining the stability of consumer goods, growth in pharmaceuticals, and innovation in medical devices. This structure makes it less susceptible to short-term economic cycles. Its performance relative to the market often demonstrates defensive properties, offering investors an island of stability.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization Johnson Johnson
Johnson & Johnson, a diversified healthcare giant, reflects the combined cycles of the pharmaceutical and medical device industries. Monthly fluctuations reflect reactions to clinical trial news, medical device sales data, and major litigation outcomes.
Monthly dynamics of market capitalization of the market segment - Holding
This chart reflects the dynamics of the diversified healthcare sector, where Johnson & Johnson is a major player. Its movements are a reflection of broader trends in pharmaceuticals, medical devices, and consumer goods. This is the backdrop against which the company has undergone its major restructuring.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
This chart reflects overall market sentiment. For Johnson & Johnson, a diversified healthcare giant, it's the backdrop. Its movements are typically smoother than those of the broader market, demonstrating the defensive nature of its business, less dependent on economic cycles.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization Johnson Johnson
Johnson & Johnson, a diversified healthcare giant, shows weekly performance dependent on news from three segments: pharmaceuticals, medical devices, and consumer goods. Lawsuits, clinical trial results, and M&A deals can cause significant short-term fluctuations.
Weekly dynamics of market capitalization of the market segment - Holding
Johnson & Johnson is a diversified giant spanning pharmaceuticals and medical devices. Its weekly performance is often more stable than that of more specialized companies in these sectors. The chart shows how diversification helps J&J smooth out industry volatility, but also sometimes lags sector leaders during periods of rapid growth.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Johnson & Johnson is a diversified healthcare giant, spanning pharmaceuticals and medical devices. This structure ensures stability. This chart shows how the company's shares, like a battleship, smooth out market waves, exhibiting less volatility than the overall stock market.
Market capitalization of the company, segment and market as a whole
JNJ - Market capitalization of the company Johnson Johnson
Johnson & Johnson's market capitalization reflects confidence in one of the most diversified healthcare giants. Its stable performance is the result of a combination of a robust consumer business (brands like Band-Aid and Tylenol), a pharmaceutical division, and medical device manufacturing. Investors value this stability, making J&J a safe haven in the sector.
JNJ - Share of the company's market capitalization Johnson Johnson within the market segment - Holding
Johnson & Johnson is a diversified healthcare giant whose market share reflects its presence in pharmaceuticals, medical devices, and consumer goods. Its consistently high market capitalization reflects brand trust and the sustainability of its decades-tested business model.
Market capitalization of the market segment - Holding
Below is a chart of the total market capitalization of diversified healthcare giants. Johnson & Johnson is one of the most prominent members of this elite club. Its businesses span everything from consumer goods to pharmaceuticals and medical devices. The size of its sector reflects demand for healthcare, and J&J's stability demonstrates the strength of its diversification.
Market capitalization of all companies included in a broad market index - GURU.Markets
Johnson & Johnson is synonymous with trust in healthcare. Its market capitalization is built on a diversified portfolio, ranging from baby powder to advanced medical equipment. The chart below demonstrates the scale of the company, which is present in every home and hospital medicine cabinet.
Book value capitalization of the company, segment and market as a whole
JNJ - Book value capitalization of the company Johnson Johnson
Johnson & Johnson's book value reflects the diversified foundation of one of the largest healthcare conglomerates, encompassing drug manufacturing plants, medical equipment, and R&D centers. The chart shows how this diversified company maintains and grows its assets across three distinct business segments.
JNJ - Share of the company's book capitalization Johnson Johnson within the market segment - Holding
Johnson & Johnson is a conglomerate whose strength lies in its vast manufacturing and research assets. The chart shows the company's share of the sector's physical assets: from consumer goods factories to sterile drug discovery labs. This is its physical legacy.
Market segment balance sheet capitalization - Holding
Johnson & Johnson is a diversified giant in the capital-intensive healthcare sector. Its portfolio of industry assets is vast, and J&J contributes to this through its manufacturing plants for consumer goods, medical devices, and sterile pharmaceuticals.
Book value of all companies included in the broad market index - GURU.Markets
Johnson & Johnson is more than a brand; it's a healthcare giant. Its net worth lies in its global network of manufacturing plants for drugs, medical devices, and consumer goods, as well as one of the industry's most valuable patent portfolios.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - Johnson Johnson
Johnson & Johnson is a conglomerate with a vast base of real assets, from factories to patents. The market values this stability and diversification. The chart shows that investors see the company as a reliable pillar of healthcare, valuing it somewhat higher than the sum of its parts due to synergies and its brand.
Market to book capitalization ratio in a market segment - Holding
Johnson & Johnson is a diversified healthcare giant, spanning consumer products, pharmaceuticals, and medical devices. Its strength lies in its brands, patents, and scale. This chart shows how the market assesses the stability and reliability of this diversified business by comparing its total market value to the book value of its extensive assets.
Market to book capitalization ratio for the market as a whole
Johnson & Johnson is a diversified healthcare giant, spanning consumer goods, pharmaceuticals, and medical devices. Against the backdrop of broader market trends illustrated in the chart, J&J's valuation reflects its stability, reliability, and broad product portfolio, which is valued by investors seeking defensive assets at a moderate premium.
Debts of the company, segment and market as a whole
JNJ - Company debts Johnson Johnson
For diversified giant Johnson & Johnson, debt is a tool for managing a complex portfolio of assets, from pharmaceuticals to medical devices. Debt capital allows it to finance R&D across various segments and make strategic acquisitions. Stable cash flows allow the company to comfortably service its significant liabilities.
Market segment debts - Holding
Johnson & Johnson is a diversified healthcare giant, spanning consumer goods, pharmaceuticals, and medical devices. This structure ensures stable cash flows, allowing it to maintain a conservative debt policy. Debt is most often used for major acquisitions. This chart reflects the company's financial strength and reliability.
Market debt in general
Johnson & Johnson is a diversified healthcare giant, producing everything from consumer goods to pharmaceuticals and medical devices. This structure provides stability but requires prudent capital management. This chart shows the overall debt picture, allowing one to assess how J&J balances investments in various segments and maintains a healthy balance sheet.
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio Johnson Johnson
Johnson & Johnson is a diversified healthcare giant, spanning consumer goods, pharmaceuticals, and medical devices. This chart shows how the company leverages its financial strength. Debt is often used to finance strategic acquisitions that expand its portfolio of patented drugs and technologies.
Market segment debt to market segment book capitalization - Holding
Johnson & Johnson is a diversified healthcare giant, spanning consumer goods, pharmaceuticals, and medical devices. This chart shows how the debt position of such a complex holding company compares to the financial health of the entire sector. It helps assess the balance of its funding strategy across its various business lines.
Debt to book value of all companies in the market
Johnson & Johnson is a diversified giant operating in relatively stable healthcare sectors. This chart compares its conservative financial policies with the overall market environment. It shows how the debt load of this mature and stable business compares to the average leverage of all publicly traded companies.
P/E of the company, segment and market as a whole
P/E - Johnson Johnson
This metric for Johnson & Johnson, a diversified healthcare giant, exemplifies a classic blue-chip stock. The company operates in the stable pharmaceutical and medical device segments. Its moderate P/E reflects expectations of reliable but slow growth, as well as stable dividends, which appeals to conservative investors.
P/E of the market segment - Holding
Johnson & Johnson is a diversified healthcare giant, producing everything from consumer goods to pharmaceuticals and medical devices. Its complex structure requires comparison. This chart shows the average valuation for healthcare holdings, giving investors a benchmark for analyzing the fair value of such a diverse corporation.
P/E of the market as a whole
Johnson & Johnson is a diversified healthcare giant, spanning consumer goods, pharmaceuticals, and medical devices. This structure makes its business less susceptible to economic cycles than the broader market. This chart helps understand how much investors are willing to pay for J&J's stability compared to riskier assets.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company Johnson Johnson
Johnson & Johnson is a diversified healthcare giant, spanning consumer products, pharmaceuticals, and medical devices. Following the spinoff of its consumer business, this chart now reflects investor expectations for growth in higher-margin segments—innovative drugs and advanced medical technologies. This is a bet on future medical breakthroughs.
%20P%2FE%20Johnson%20Johnson&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-Johnson-Johnson&v=1772603082151 "Chart of the company's future (projected) P/E Johnson Johnson")
Future (projected) P/E of the market segment - Holding
Johnson & Johnson is a diversified healthcare giant, producing everything from consumer goods to advanced medical equipment and pharmaceuticals. This chart shows how the market views this conglomerate's prospects. Comparing it to its sector helps us understand whether investors see synergies in its businesses or prefer more specialized players.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Holding&v=1772603082218 "Future (projected) P/E graph of the market segment - Holding")
Future (projected) P/E of the market as a whole
Johnson & Johnson is a diversified healthcare giant, spanning consumer goods, pharmaceuticals, and medical devices. This structure provides resilience across the economic cycle. When overall market expectations, as shown in this chart, decline, investors often seek refuge in reliable and predictable companies like J&J.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772603082342 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit Johnson Johnson
Johnson & Johnson is a diversified healthcare giant. Its revenue is generated by three main segments: pharmaceuticals, medical devices, and consumer goods. This chart shows the combined performance of these segments, reflecting both advances in drug discovery and the stability of demand for healthcare products.
Profit of companies in the market segment - Holding
Johnson & Johnson is a diversified healthcare giant with operations spanning pharmaceuticals and advanced medical devices. This structure allows the company to maintain stability, balancing breakthrough but risky drugs with robust demand for medical technologies. Its combined performance mitigates volatility and forms the foundation of the sector's profitability.
Overall market profit
Johnson & Johnson is a diversified healthcare giant, producing pharmaceuticals, medical devices, and consumer products. With a broad product portfolio ranging from cancer treatments to baby shampoo, the company demonstrates stability across the economic cycle, contributing significantly to overall corporate profits.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company Johnson Johnson
After spinning off its consumer business, Johnson & Johnson focused on pharmaceuticals and medical devices. This chart shows analysts' expectations for sales of prescription drugs and innovative medical devices. Successful clinical trials and the launch of new products are key to future profits.
%20profit%20of%20the%20company%20Johnson%20Johnson&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-Johnson-Johnson&v=1772603082618 "Graph of future (projected) profit of the company Johnson Johnson")
Future (predicted) profit of companies in the market segment - Holding
Johnson & Johnson is a diversified healthcare giant focused on pharmaceuticals and medical devices. The chart shows revenue forecasts for the entire industry, allowing investors to assess how J&J's innovative developments and broad product portfolio align with the overall growth prospects of the healthcare sector.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Holding&v=1772603082707 "Graph of future (predicted) profits of companies in a market segment - Holding")
Future (predicted) profit of the market as a whole
This chart illustrates expectations for a diversified healthcare giant. Johnson & Johnson's profit forecast depends on the performance of three key segments: pharmaceuticals, medical devices, and consumer products. These dynamics reflect market confidence in the success of new drugs and the robust demand for medical products.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772603082731 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - Johnson Johnson
Johnson & Johnson is a diversified healthcare giant with businesses in pharmaceuticals, medical devices, and consumer goods. This chart reflects how investors perceive the stability and reliability of its total revenue. The multiple often represents a premium for its low risk and broad presence in the healthcare market.
P/S market segment - Holding
Johnson & Johnson is a diversified healthcare giant, producing everything from consumer products (like bandages and shampoos) to complex medical equipment and pharmaceuticals. This chart reflects the industry's average revenue estimate, providing an indication of how investors value J&J's stability and broad diversification.
P/S of the market as a whole
Johnson & Johnson is a diversified healthcare giant with revenues derived from pharmaceuticals, medical devices, and consumer products. This chart serves as a broad market indicator of revenue valuation. For J&J, it helps investors understand how the market views this diversification—as a source of stability or a factor that slows growth.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company Johnson Johnson
Johnson & Johnson is a diversified healthcare giant focused on pharmaceuticals and medical devices. Its future revenue estimates depend on the success of new drugs and demand for medical devices. This chart reflects investor expectations regarding the company's R&D pipeline and its ability to bring new, in-demand medical solutions to market.
%20P%2FS%20Johnson%20Johnson&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-Johnson-Johnson&v=1772603082833 "The graph of the company's future (projected) P/S Johnson Johnson")
Future (projected) P/S of the market segment - Holding
Johnson & Johnson is a diversified healthcare giant, producing everything from consumer goods to pharmaceuticals and medical devices. This chart shows how the market values its future earnings. Does diversification offer a premium on stability, or do investors value focused biotech and medtech companies more?
%20P%2FS%20market%20segment%20graph%20-%20Holding&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Holding&v=1772603082845 "Future (projected) P/S market segment graph - Holding")
Future (projected) P/S of the market as a whole
Johnson & Johnson is a diversified healthcare giant, producing pharmaceuticals, medical devices, and consumer products. Its stable revenue underpins overall market expectations, as shown in the chart. The company's success across multiple segments demonstrates robust demand for healthcare products, regardless of economic cycles.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772603082859 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales Johnson Johnson
Johnson & Johnson is a diversified healthcare giant operating in three segments: consumer products, pharmaceuticals, and medical devices. This chart reflects combined sales from products as diverse as baby shampoo, life-saving medications, and high-tech surgical equipment.
Sales of companies in the market segment - Holding
Johnson & Johnson is a diversified healthcare giant, producing pharmaceuticals, medical devices, and consumer products. The company's stability stems from its broad market reach. This chart shows total sector revenue, helping to assess the size and dynamics of the healthcare market, in which J&J is a key player.
Overall market sales
Johnson & Johnson is a diversified healthcare giant, producing everything from consumer goods to pharmaceuticals and medical devices. The company touches the lives of nearly everyone. This graph, reflecting the overall state of the economy, indirectly impacts J&J, as it influences consumer activity and healthcare budgets.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company Johnson Johnson
Johnson & Johnson is a diversified healthcare giant, producing both pharmaceuticals and medical devices. The company's future revenue depends on the success of new drugs and demand for medical technologies. This chart summarizes analyst forecasts for both segments, reflecting their views on global healthcare trends.
%20sales%20of%20the%20company%20Johnson%20Johnson&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-Johnson-Johnson&v=1772603082998 "Schedule of future (projected) sales of the company Johnson Johnson")
Future (projected) sales of companies in the market segment - Holding
Johnson & Johnson is a diversified healthcare giant, producing pharmaceuticals, medical devices, and consumer products. This chart displays projected revenues for the entire healthcare industry. It provides a general overview of healthcare spending trends, which are fundamental to all three of J&J's business segments.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Holding&v=1772603083083 "Schedule of future (projected) sales of companies in the market segment - Holding")
Future (projected) sales of the market as a whole
Johnson & Johnson is a diversified healthcare giant that produces drugs, medical devices, and consumer products. While demand for many of its products is stable, the medical device segment is sensitive to economic conditions, as elective surgeries may be postponed. This chart helps assess the overall ability of the healthcare system and patients to finance such procedures.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772603083118 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality Johnson Johnson
Johnson & Johnson is a diversified healthcare giant, producing consumer products, medical devices, and pharmaceuticals. This chart shows the combined sales of Band-Aid bandages, high-tech medical devices, and patented drugs, reflecting the resilience and breadth of the company's business empire.
Market segment marginality - Holding
Johnson & Johnson is a diversified healthcare giant operating across three segments: pharmaceuticals, medical devices, and consumer products. This diversity provides resilience to market fluctuations. This metric reflects how synergies across segments and strong brands enable the company to maintain above-average profitability.
Market marginality as a whole
Johnson & Johnson is a diversified giant operating in three segments: pharmaceuticals, medical devices, and consumer goods. This chart shows average profitability across the economy. It demonstrates how diversification helps mitigate risk and maintain stable profitability, as demand for healthcare products is less susceptible to cycles.
Employees in the company, segment and market as a whole
Number of employees in the company Johnson Johnson
Johnson & Johnson is a diversified healthcare giant, producing everything from consumer products to complex medical devices and pharmaceuticals. This chart shows the combined size of its three business segments. Changes in headcount may reflect growth in one segment, major acquisitions, or asset restructuring.
Share of the company's employees Johnson Johnson within the market segment - Holding
This chart illustrates Johnson & Johnson's diversified strength in the healthcare sector. Its vast workforce is spread across three key businesses: pharmaceuticals, medical devices, and consumer products. This demonstrates the company's deep penetration into all aspects of human health, supported by a vast workforce of specialists.
Number of employees in the market segment - Holding
Johnson & Johnson is a diversified healthcare giant, producing everything from consumer goods to pharmaceuticals and medical devices. The complexity and diversity of its business require a vast workforce of diverse specialists. This chart illustrates the scale of the sector, where J&J is one of the most stable and largest employers.
Number of employees in the market as a whole
Johnson & Johnson is a diversified healthcare giant operating in three segments: pharmaceuticals, medical devices (MedTech), and consumer products. This graph of total employment reflects the state of the insurance system. Most employees in the US have health insurance, which covers procedures using JNJ medical devices and their prescription medications.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company Johnson Johnson (JNJ)
Johnson & Johnson is a diversified giant spanning pharmaceuticals, medical devices, and consumer goods. This graph is an average across all segments. It's high in pharmaceuticals due to patents, while it's lower in other segments. The graph illustrates this mixed assessment of the contribution of each employee within a massive corporation.
%20of%20the%20company%20Johnson%20Johnson%20(JNJ)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-Johnson-Johnson-JNJ&v=1772603083380 "Chart of market capitalization per employee (in thousands of dollars) of the company Johnson Johnson (JNJ)")
Market capitalization per employee (in thousands of dollars) in the market segment - Holding
After spinning off its consumer segment, J&J focused on high-margin businesses: pharmaceuticals and MedTech (medical equipment). These industries require elite R&D specialists and sophisticated manufacturing. This chart shows how the market values the "new" J&J per employee in this research-intensive business.
%20by%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Holding&v=1772603083381 "Market capitalization per employee (in thousands of dollars) by market segment - Holding")
Market capitalization per employee (in thousands of dollars) for the overall market
Johnson & Johnson is a diversified healthcare holding company, spanning consumer goods, pharmaceuticals, and medical devices. This chart shows the average valuation across all segments. Analyzing the dynamics helps understand how the market values the synergies between labor-intensive consumer goods manufacturing and capital-intensive pharmaceutical development.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772603083394 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company Johnson Johnson (JNJ)
Johnson & Johnson is a diversified healthcare giant, spanning pharmaceuticals and medical devices. This chart reflects the combined performance of thousands of scientists, engineers, and managers. Success in R&D and strong patents in both areas (drugs and devices) allow the company to maintain high profitability per employee.
%20Chart%20Johnson%20Johnson%20(JNJ)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-Johnson-Johnson-JNJ&v=1772603083445 "Company Profit Per Employee (in thousands of dollars) Chart Johnson Johnson (JNJ)")
Profit per employee (in thousands of dollars) in the market segment - Holding
Johnson & Johnson is a diversified healthcare holding company. This chart shows the average for this segment. This benchmark combines different areas: high-margin pharmaceuticals (R&D) and more capital-intensive medical device manufacturing. It represents the benchmark for a diversified approach to medicine.
%20in%20the%20market%20segment%20-%20Holding&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Holding&v=1772603083536 "Chart of profit per employee (in thousands of dollars) in the market segment - Holding")
Profit per employee (in thousands of dollars) for the market as a whole
Johnson & Johnson is a diversified healthcare giant producing pharmaceuticals, medical devices, and consumer products. The company's strength lies in its brands and scientific research. This metric reflects how investments in R&D and marketing create high-value products, delivering high profitability per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772603083612 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee Johnson Johnson (JNJ)
Johnson & Johnson is a diversified healthcare giant, spanning consumer goods, pharmaceuticals, and medical devices. This chart averages the performance of its various segments. Its strong performance is driven by patented drugs and sophisticated equipment, where each employee's contribution creates significant added value.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-Johnson-Johnson-JNJ&v=1772603083663 "Sales chart per company employee Johnson Johnson (JNJ)")
Sales per employee in the market segment - Holding
Johnson & Johnson is a diversified healthcare giant producing pharmaceuticals, medical devices, and consumer products. This chart shows the average revenue per employee in this segment. It allows one to evaluate the overall productivity of employees across these different areas compared to other large healthcare companies.
Sales per employee for the market as a whole
Johnson & Johnson is a diversified healthcare giant, spanning consumer products (like patches) to complex medical equipment and pharmaceuticals. This metric reflects average performance across all segments. Patented drugs and high-tech medical devices make the largest contribution, as intellectual property generates more revenue than labor alone.
Short shares by company, segment and market as a whole
Shares shorted by company Johnson Johnson (JNJ)
Johnson & Johnson is a diversified giant that produces medical devices and pharmaceuticals. The bearish bets visible on this chart are often linked to legal risks. Multi-year lawsuits (such as those related to talc) create uncertainty and could lead to multibillion-dollar fines, which attracts bears.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-Johnson-Johnson-JNJ&v=1772603083940 "Short Shares Chart for the Company Johnson Johnson (JNJ)")
Shares shorted by market segment - Holding
Johnson & Johnson is a diversified healthcare giant focused on pharmaceuticals and advanced medical devices (MedTech). This chart shows the overall investor pessimism toward the entire sector. It reflects market concerns about healthcare reform and patent expirations in the pharmaceutical industry as a whole.
Shares shorted by the overall market
Johnson & Johnson is a diversified giant producing drugs and medical devices. Demand for its products is largely independent of economic cycles. This chart measures overall market fear. When fear rises, investors seek safe havens. J&J, with its stable cash flows and dividends, often becomes such a "safe haven" asset.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator Johnson Johnson (JNJ)
Johnson & Johnson, a diversified healthcare giant (pharma, medical technology), is typically stable. Values above 70 on this indicator may reflect the success of new drugs or confidence in earnings stability. A drop below 30 may be due to concerns about lawsuits or uncertainty following major restructurings.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-Johnson-Johnson-JNJ&v=1772603083969 "RSI 14 indicator chart for the company's stock Johnson Johnson (JNJ)")
RSI 14 Market Segment - Holding
Johnson & Johnson (JNJ) is a diversified healthcare giant that, after spinning off its consumer business (Kenvue), focused on pharmaceuticals and medical devices. This metric measures the "temperature" of the sector. It helps understand: is JNJ moving as a "defensive" asset or is the entire sector "oversold" due to patent collapses and regulatory risks?
RSI 14 for the overall market
Johnson & Johnson is a diversified giant, spanning from medical devices (MedTech) to innovative pharmaceuticals. It's a classic "defensive" stock. This indicator shows when the overall market is swinging to extremes (panic or euphoria). This helps us understand whether J&J truly serves as a safe haven or is being carried along by the overall emotional tide.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast JNJ (Johnson Johnson)
For Johnson & Johnson, this chart reflects analysts' views on its "new" strategy. Following the spinoff of its consumer business (Kenvue), analysts are focusing exclusively on the MedTech (medical equipment) and Pharma segments. Their price targets depend on the success of new drugs (like Carvykti) and growing sales of surgical equipment, as well as the risks associated with the old talc lawsuits.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-JNJ-Johnson-Johnson&v=1772603084103 "A chart showing analyst consensus forecasts for the expected stock price. JNJ (Johnson Johnson)")
The difference between the consensus estimate and the actual stock price JNJ (Johnson Johnson)
Johnson & Johnson, after spinning off its consumer business, focused on pharmaceuticals and advanced medical devices (MedTech). This chart measures the gap between analyst estimates and the current price. It shows whether experts believe the rejuvenated J&J can generate growth through innovation in oncology and surgery, and whether they see underappreciated potential in this area.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-JNJ-Johnson-Johnson&v=1772603084203 "A chart showing the difference between the consensus forecast and the actual stock price. JNJ (Johnson Johnson)")
Analyst consensus forecast for stock prices by market segment - Holding
Johnson & Johnson is a diversified healthcare giant focused on pharmaceuticals and advanced medical devices (MedTech). This chart reflects analyst expectations for the entire healthcare sector. It shows whether experts in this "defensive" industry see growth potential or anticipate stagnation.
Analysts' consensus forecast for the overall market share price
Johnson & Johnson is one of the most defensive assets, a giant in the pharmaceutical and medical technology industries. Demand for its products is stable. However, during periods of market panic, investors sell everything. This chart shows the overall sentiment of analysts. It helps us understand: is fear or greed driving the market? This influences how investors value even the most reliable companies like JNJ.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index Johnson Johnson
Johnson & Johnson is a diversified healthcare giant. After spinning off its consumer business (Kenvue), the company focused on two pillars: pharmaceuticals and advanced medical devices (MedTech). This chart reflects the combined value of their robust medical devices business and the potential of their pharmaceutical pipeline.
AKIMA Market Segment Index - Holding
Johnson & Johnson is a diversified healthcare giant focused on pharmaceuticals and advanced medical devices (MedTech). This comprehensive index evaluates stability and innovation. The chart shows the average value for the segment, helping investors understand how J&J's diversification allows it to outperform the sector average.
The AKIM Index for the overall market
Johnson & Johnson is a diversified healthcare giant focused on innovative medicines (Pharma) and medical devices (MedTech). This sector is less susceptible to economic cycles. This chart, showing the average market backdrop, serves as a benchmark. It helps investors understand how J&J's stable business compares to overall macroeconomic fluctuations and market sentiment.
